Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database.

Autor: Alexandre J; Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France. joachim.alexandre@unicaen.fr.; Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Department of Pharmacology, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France. joachim.alexandre@unicaen.fr., Font J; Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France.; Caen-Normandy University Hospital, Department of Cardiology, Avenue de la Côte de Nacre, F-14000, Caen, France., Angélique DS; Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France.; Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Departments of Pharmacology and Medical Oncology, Avenue de la Côte de Nacre, F-14000, Caen, France., Delapierre B; Caen-Normandy University Hospital, Hematology Institute, Avenue de la Côte de Nacre, F-14000, Caen, France., Damaj G; Caen-Normandy University Hospital, Hematology Institute, Avenue de la Côte de Nacre, F-14000, Caen, France., Plane AF; Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Department of Cardiology, Avenue de la Côte de Nacre, F-14000, Caen, France., Legallois D; Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France.; Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Department of Cardiology, Avenue de la Côte de Nacre, F-14000, Caen, France., Milliez P; Caen-Normandy University Hospital, Department of Cardiology, Avenue de la Côte de Nacre, F-14000, Caen, France.; Normandie Univ, UNICAEN, INSERM U1237 PhIND, GIP Cyceron, Boulevard Henri Becquerel, F-14000, Caen, France., Dolladille C; Normandie Univ, UNICAEN, INSERM U1086 ANTICIPE, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France.; Caen-Normandy University Hospital, PICARO Cardio-Oncology Program, Department of Pharmacology, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France., Chrétien B; Caen-Normandy University Hospital, Centre Régional de PharmacoVigilance, Department of Pharmacology, Biology-Research Building, Avenue de la Côte de Nacre, F-14000, Caen, France.

Publikováno v: Leukemia [Leukemia] 2024 Dec; Vol. 38 (12), pp. 2628-2635. Date of Electronic Publication: 2024 Sep 19.